134 related articles for article (PubMed ID: 6798720)
1. Serial free and plasma valproic acid and phenytoin monitoring and drug interactions.
Haidukewych D; Rodin EA
Ther Drug Monit; 1981; 3(3):303-7. PubMed ID: 6798720
[TBL] [Abstract][Full Text] [Related]
2. Drug interaction between phenytoin and valproic acid in a child with refractory epilepsy: a case report.
Carvalho IV; Carnevale RC; Visacri MB; Mazzola PG; de Fátima Lopes Ambrósio R; dos Reis MC; de Queiroz RA; Moriel P
J Pharm Pract; 2014 Apr; 27(2):214-6. PubMed ID: 24381240
[TBL] [Abstract][Full Text] [Related]
3. Monitoring free valproic acid in epilepsy patients medicated with coanticonvulsants.
Haidukewych D; Rodin EA
Ther Drug Monit; 1982; 4(2):209-12. PubMed ID: 6808716
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid-phenytoin interaction.
Friel PN; Leal KW; Wilensky AJ
Ther Drug Monit; 1979; 1(2):243-8. PubMed ID: 122160
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent interaction between phenytoin and valproic acid.
Riva R; Albani F; Contin M; Perucca E; Ambrosetto G; Gobbi G; Santucci M; Procaccianti G; Baruzzi A
Neurology; 1985 Apr; 35(4):510-5. PubMed ID: 3920548
[TBL] [Abstract][Full Text] [Related]
6. A correlation between the levels of phenobarbital, phenytoin and valproic acid in the blood serum and in saliva from children treated due to epilepsy.
Sobaniec W
Mater Med Pol; 1989; 21(4):323-6. PubMed ID: 2489248
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid and plasma levels of phenytoin.
Bruni J; Wilder BJ; Willmore LJ; Barbour B
Neurology; 1979 Jun; 29(6):904-5. PubMed ID: 377134
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring of antiepileptic drugs.
Shakya G; Malla S; Shakya KN; Shrestha R
JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
[TBL] [Abstract][Full Text] [Related]
9. Effect of valproate on free plasma phenytoin concentrations.
Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
[TBL] [Abstract][Full Text] [Related]
10. Predictability of unbound antiepileptic drug concentrations in children treated with valproic acid and phenytoin.
Miles MV; Snead OC; Thorn MD
Clin Pharm; 1988 Sep; 7(9):688-93. PubMed ID: 3149223
[No Abstract] [Full Text] [Related]
11. Fluctuations of unbound and total phenytoin concentrations during the day in epileptic patients on valproic acid comedication.
May T; Rambeck B
Ther Drug Monit; 1990 Mar; 12(2):124-8. PubMed ID: 2107607
[TBL] [Abstract][Full Text] [Related]
12. Derivation and evaluation of an equation for prediction of free phenytoin concentration in patients co-medicated with valproic acid.
Haidukewych D; Rodin EA; Zielinski JJ
Ther Drug Monit; 1989; 11(2):134-9. PubMed ID: 2497562
[TBL] [Abstract][Full Text] [Related]
13. Decreased plasma protein binding of phenytoin in patients on valproic acid.
Dahlqvist R; Borgå O; Rane A; Walsh Z; Sjöqvist F
Br J Clin Pharmacol; 1979 Dec; 8(6):547-52. PubMed ID: 391256
[TBL] [Abstract][Full Text] [Related]
14. Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy.
Shakir RA; Johnson RH; Lambie DG; Melville ID; Nanda RN
Epilepsia; 1981 Feb; 22(1):27-33. PubMed ID: 6781888
[TBL] [Abstract][Full Text] [Related]
15. Elevated free phenytoin and free valproic acid concentrations in sera of patients infected with human immunodeficiency virus.
Dasgupta A; McLemore JL
Ther Drug Monit; 1998 Feb; 20(1):63-7. PubMed ID: 9485557
[TBL] [Abstract][Full Text] [Related]
16. The effect of combination therapy on the plasma concentrations of traditional antiepileptics: a retrospective study.
Sirmagul B; Atli O; Ilgin S
Hum Exp Toxicol; 2012 Oct; 31(10):971-80. PubMed ID: 22588177
[TBL] [Abstract][Full Text] [Related]
17. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.
Knott C; Hamshaw-Thomas A; Reynolds F
Br Med J (Clin Res Ed); 1982 Jan; 284(6308):13-6. PubMed ID: 6797618
[TBL] [Abstract][Full Text] [Related]
18. Nomogram for the prediction of unbound phenytoin concentrations in patients on a combined treatment of phenytoin and valproic acid.
May TW; Rambeck B; Nothbaum N
Eur Neurol; 1991; 31(1):57-60. PubMed ID: 2015840
[TBL] [Abstract][Full Text] [Related]
19. Serum protein binding of diphenylhydantoin in man. II. Interaction with sodium valproate in epileptic patients.
Gatti G; Lecchini S; Frigo GM; Visintini D; Calzetti S; Lombardi M; Cattaino G
Farmaco Prat; 1979 Jan; 34(1):46-8. PubMed ID: 378689
[No Abstract] [Full Text] [Related]
20. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
Kerrick JM; Wolff DL; Graves NM
Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]